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Background/introduction
With regards to MR-HIFU ablation of uterine fibroids,
there have been no screening MR criteria that comprehen-
sively consider multiple influencing factors. The aims of
this study was to generate screening MRI-based prediction
model for therapeutic responses of MR-guided high-inten-
sity focused ultrasound (MR-HIFU) ablation of uterine
fibroids comprehensively considering multiple influencing
factors.
Methods
A total of 160 symptomatic uterine fibroids (diameter
8.3cm, range 3.1-15.0cm) in 112 women (age 43.3, range
25-55) who were treated with MR-HIFU ablation were
retrospectively analyzed. The following three parameters
of screening MRI were evaluated. 1) Subcutaneous fat
was measured as a thickness of the most compressed
point (mm) on prone position. 2) Relative peak
enhancement (%) was calculated based on time-signal
intensity curve analysis of fibroid in perfusion MRI (100
dynamics, 3s time resolution), in which 0% refers the
same signal intensity as in precontrast image. 3) Signal
intensity was assessed as a ratio of T2 signal intensity of
uterine fibroids to that of skeletal muscle. Those para-
meters were used to generate prediction models with
regards to ablation efficiency (i.e., non-perfused volume/
treatment cell volume) and ablation quality (grade 1~5,
from poor to excellent), respectively, using generalized
estimating equation (GEE) analysis. Then, cut-off values
for successful treatment (ablation efficiency >1.0; ablation
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quality grade 4 or 5) were determined based on receiver
operating characteristic (ROC) curve analyses.
Results and conclusions
GEE analyses produced the models of “y1=2.2637–
0.0415x1–0.0011x2–0.0772x3” and “y2=6.8148–0.1070x1–
0.0050x2–0.2163x3”, where y1=ablation efficiency,
y2=ablation quality, x1=subcutaneous fat thickness,
x2=relative peak enhancement, and x3=T2 signal intensity
ratio (p-values for x1, 0.0068 and <0.0001; for x2, 0.1952
and 0.0001; for x3, <0.0001 and <0.0001, respectively).
Cut-off values for successful treatments based on ROC
curve analyses turned out to be 1.312 for of ablation effi-
ciency (AUC, .7236; sensitivity, .6882; specificity, .6866)
and 4.019 for ablation quality (AUC, .8794; sensitivity,
.7156; specificity, .9020).
Conclusion: Simple equation models to predict thera-
peutic responses of MR-HIFU ablation of uterine
fibroids in terms of ablation efficiency and quality were
generated, which are easily applicable to screening MRI.
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